In a real-world trial, a team of clinician-researchers at Beth Israel Deaconess Medical Center have demonstrated that tests of self-collected saliva provided comparable results to tests performed by trained healthcare professionals using NP swabs.
With the goal of dramatically accelerating discoveries in health and disease, Beth Israel Deaconess Medical Center has opened a Spatial Technologies Unit, the first center in Massachusetts and one of the first of its kind worldwide. The new space will provide access to ground-breaking technologies that allow scientists to examine cells as they function within intact tissues. Made possible by a grant from the Massachusetts Life Sciences Center, the BIDMC unit will be a nexus of the state’s precision medicine community, empowering researchers across healthcare, academia, research and industry.
A study conducted by clinician-researchers at Beth Israel Deaconess Medical Center (BIDMC) found older patients with chronic conditions and their caregivers can benefit from accessing their medical appointment notes.
In a new study, a multi-disciplinary team of researchers has demonstrated that a metabolic regulatory molecule called Them1 prevents fat burning in cells by blocking access to their fuel source, which may contribute to the development of a new type of obesity treatment.
A study sheds new light on the complex interplay among the neurons that govern hunger, behavior and learning.
Shekar will lead the department’s efforts to treat patients with cutting edge surgical approaches, train the next generation of cardiothoracic surgeons and move the field forward through rigorous research.
Researchers report that about a quarter of localized prostate cancers may demonstrate immunologic traits that suggest a substantial number of patients with prostate cancer may benefit from immunotherapies.
Beth Israel Lahey Health (BILH) and Joslin Diabetes Center (Joslin) have signed a definitive agreement under which Joslin will join BILH and bring to the system its expertise as a world-renowned center of excellence in diabetes research, education and clinical care.
In a new paper published in the journal Circulation, researchers built a model to examine the potential impact of implementing similar blood pressure control programs at barbershops nationwide. Modeled off a 2018 randomized trial called the Los Angeles Barbershop Blood Pressure Study (LABBS), the team found that such programs could reach one in three Black men with uncontrolled blood pressure nationally.
Researchers report on how a diverse cohort of gynecologic cancer patients are affected by financial distress, also called “financial toxicity” in acknowledgment of the health hazards it can pose, in the International Journal of Gynecological Cancer.
In a new study published in Nature, Dan Barouch, MD, PhD, Director of BIDMC's Center for Virology and Vaccine Research, and colleagues report on the antibody and cellular immune responses generated by the Ad26.COV2.S vaccine against the original viral strain and against SARS-CoV-2 variants of concern. The team found that this vaccine induced immune responses against all the viral variants.
A new study led by investigators at Beth Israel Deaconess Medical Center (BIDMC) provides insights into the mechanistic links between physical fitness and overall health, as well as the reasons why the same exercise can have different effects in different people.
A team at BIDMC found that the year-over-year increase in deaths due to heart disease and cerebrovascular disease was significantly more pronounced among Black, Hispanic and Asian populations in the United States than in the non-Hispanic white population.
Cardiologists at Beth Israel Deaconess Medical Center (BIDMC), designed the Safety Assessment of Femoropopliteal Endovascular Treatment With Paclitaxel-coated Devices (SAFE-PAD) study to provide the information necessary to make scientifically-sound regulatory decisions about the safety of these devices.
In a new study, clinician-researchers at Beth Israel Deaconess Medical Center (BIDMC) analyzed naloxone prescription trends during the COVID-19 pandemic in the United States and compared them to trends in opioid prescriptions and to overall prescriptions.
In a new study from Beth Israel Deaconess Medical Center researchers evaluated the immunogenicity of COVID-19 mRNA vaccines in pregnant and lactating women who received either the Pfizer or Moderna COVID-19 vaccines. They found that both vaccines triggered immune responses in pregnant and lactating women.
Beth Israel Lahey Health announced the appointment of Juan Fernando Lopera as its inaugural Chief Diversity, Equity and Inclusion Officer.
Beth Israel Deaconess Hospital – Plymouth (BID Plymouth) has received five-out-of-five stars from the federal Centers for Medicare and Medicaid Services (CMS) in its annual quality and safety assessment of more than 4,500 hospitals across the country.
Beth Israel Deaconess Hospital – Needham (BID Needham) has received five-out-of-five stars from the federal Centers for Medicare and Medicaid Services (CMS) in its annual quality and safety assessment of more than 4,500 hospitals across the country.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right